Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor ProgressionDouglas S. Micalizzi, Heide L. Ford|Journal of Mammary Gland Biology and Neoplasia|2010Cited by 972
Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathwaysRitsuko Iwanaga, Heide L. Ford|Breast Cancer Research|2012Cited by 90
Eya3 partners with PP2A to induce c-Myc stabilization and tumor progressionLingdi Zhang, Heide L. Ford|Nature Communications|2018Cited by 81
Vascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3Chu-An Wang, Heide L. Ford|Breast Cancer Research|2014Cited by 56
SIX2 Mediates Late-Stage Metastasis via Direct Regulation of <i>SOX2</i> and Induction of a Cancer Stem Cell ProgramMichael Oliphant, Heide L. Ford, Melanie Y. Vincent et al.|Cancer Research|2019Cited by 50